Wednesday, 18 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

6:01 AM ET 8-K
Stock Plan Amendment Liberty Star Uranium & Metals Corp. LBSR

Liberty Star Uranium & Metals Stock Plan Amendment

Liberty Star Uranium & Metals Corp. awarded 11,750,000 non-qualified stock options to its board, officers, and managers, including milestone-based tranches for the Chairman. The company also announced it will seek shareholder approval for a new 25,000,000-share 2026 Equity Incentive Plan to facilitate future employee awards and registration on Form S-8.

Term
10 years
6:01 AM ET 10-Q
Financial Results FutureCorp Space Acquisition 1 FTRA

FutureCorp Space Acquisition 1 Q3 2026 Results: Net Income $1.91M

FutureCorp Space Acquisition 1, a special purpose acquisition company, filed its 10-Q on November 3, 2026. The report details the company's ongoing efforts to identify a target for a business combination in the space sector, with financial results primarily reflecting administrative expenses and interest income from its trust account.

Key figure
Net income $1.91M
6:01 AM ET 8-K
Court & Legal Update 3M Co MMM

3M Court & Legal Update

3M entered into a $7.35 billion nominal settlement ($5.8 billion present value) to resolve the vast majority of PFAS-related personal injury claims in the Aqueous Film-Forming Foam (AFFF) multi-district litigation. The settlement involves approximately 115,000 to 120,000 eligible plaintiffs and includes payments scheduled through 2034 to manage legacy litigation risks.

Counterparty
AFFF MDL Personal Injury Claimants
Term
2026-2034
6:00 AM ET 10-Q
Financial Results Primoris Services Corp PRIM

Primoris Services Q3 2026 Results: Net Income $51.3M, Down 45.8% YoY

Primoris Services Corp reported a significant decrease in net income for the nine months ended September 30, 2026, falling to $44.6 million from $223.2 million in the prior year period. This decline was driven by lower revenues of $5.2 billion compared to $5.7 billion and a substantial reduction in gross profit margins.

Key figure
Net income $51.3M · -45.8% YoY
6:00 AM ET 10-Q
Financial Results QuidelOrtho Corp QDEL ▶ Call

QuidelOrtho Q3 2026 Results: Net Loss of $53.8M, Loss Narrows

QuidelOrtho reported a net loss of $53.8 million for the third quarter of 2026, a significant improvement from the $733.0 million loss in the prior year which was driven by a large goodwill impairment. Total revenues decreased to $618.9 million from $699.9 million year-over-year, while the company's accumulated deficit grew to $1,234.5 million.

Key figure
Net loss $53.8M
6:00 AM ET 10-Q
Financial Results Astera Labs, Inc. ALAB

Astera Labs Q3 2026 Results: Net Income $183M, Up 100.8% YoY

Astera Labs, Inc. filed its 10-Q for the quarter ended September 30, 2026, reporting 174,782,075 shares of common stock outstanding as of October 31, 2026. The company is classified as a large accelerated filer and highlights significant risks related to customer concentration, AI technology adoption, and global supply chain management.

Key figure
Net income $183M · +100.8% YoY
9:45 PM ET Form 4
Insider Selling Glaukos Corp GKOS

Glaukos Chief Development Officer Tomas Navratil Sells $10.6M of Stock

Tomas Navratil, Chief Development Officer, sold 44,436 shares of Glaukos Corp at $237.54 to $240.52 a share (average $238.97) in 4 transactions, worth $10.6M in total on Oct 30, 2026. Shares held after the trade: 37,328 (-14.7%).

Value
$10.6M
Shares
44,436
Average price
$238.97
Role
Chief Development Officer
Holding change
-14.7%
Trade date
Oct 30, 2026
9:30 PM ET Form 4
Insider Buying Sirius Xm Holdings Inc. SIRI

Sirius Xm Holdings 10% Owner Berkshire Hathaway Inc Buys $26.9M of Stock

Berkshire Hathaway Inc, 10% Owner, bought 924,281 shares of Sirius Xm Holdings Inc. at $28.89 to $30.23 a share (average $29.10) in 3 transactions, worth $26.9M in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 125,731,398 (+0.1%).

Value
$26.9M
Shares
924,281
Average price
$29.10
Role
10% Owner
Holding change
+0.1%
Trade date
Oct 30, 2026 to Nov 3, 2026
9:26 PM ET Form 4
Insider Selling Palo Alto Networks Inc PANW

Palo Alto Networks President William D. Jenkins Jr. Sells $6.54M of Stock

William D. Jenkins Jr., President, sold 18,222 shares of Palo Alto Networks Inc at $351.46 to $366.86 a share (average $359.07) in 16 transactions, worth $6.54M in total on Nov 2, 2026. Shares held after the trade: 255,331 (-0.0%).

Value
$6.54M
Shares
18,222
Average price
$359.07
Role
President
Holding change
-0.0%
Trade date
Nov 2, 2026
9:14 PM ET Form 4
Insider Selling Agilysys Inc AGYS

Agilysys CFO William David Wood III Sells $111K of Stock

William David Wood III, CFO, sold 961 shares of Agilysys Inc at $116.00 a share, worth $111K in total on Nov 2, 2026. Shares held after the trade: 35,872 (-2.6%).

Value
$111K
Shares
961
Price
$116.00
Role
CFO
Holding change
-2.6%
Trade date
Nov 2, 2026
9:12 PM ET Form 4
Insider Selling Elevra Lithium Ltd ELVR

Elevra Lithium President Canada & Group COO Sylvain Collard Sells $70.2K of Stock

Sylvain Collard, President Canada & Group COO, sold 32,651 shares of Elevra Lithium Ltd at $2.15 a share, worth $70.2K in total on Nov 2, 2026. Shares held after the trade: 102,911 (-24.1%).

Value
$70.2K
Shares
32,651
Price
$2.15
Role
President Canada & Group COO
Holding change
-24.1%
Trade date
Nov 2, 2026
8:44 PM ET Form 4
Insider Selling Replimune Group, Inc. REPL

Replimune Group Insider Kapil Dhingra Sells $408K of Stock

Kapil Dhingra sold 21,500 shares of Replimune Group, Inc. at $19.00 a share, worth $408K in total on Nov 2, 2026. Shares held after the trade: 21,669 (-49.8%).

Value
$408K
Shares
21,500
Price
$19.00
Holding change
-49.8%
Trade date
Nov 2, 2026
8:42 PM ET Form 4
Insider Selling Amalgamated Financial Corp. AMAL

Amalgamated Financial Insider United Workers Sells $3.82M of Stock

United Workers sold 76,000 shares of Amalgamated Financial Corp. at $49.97 to $50.81 a share (average $50.31) in 3 transactions, worth $3.82M in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 6,840,216 (-0.2%).

Value
$3.82M
Shares
76,000
Average price
$50.31
Holding change
-0.2%
Trade date
Oct 30, 2026 to Nov 3, 2026
8:42 PM ET Form 4
Insider Selling Amalgamated Financial Corp. AMAL

Amalgamated Financial Insider States Regional Joint Board Workers United Western Sells $3.82M of Stock

States Regional Joint Board Workers United Western sold 76,000 shares of Amalgamated Financial Corp. at $49.97 to $50.81 a share (average $50.31) in 3 transactions, worth $3.82M in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 6,840,216 (-0.2%).

Value
$3.82M
Shares
76,000
Average price
$50.31
Holding change
-0.2%
Trade date
Oct 30, 2026 to Nov 3, 2026
8:37 PM ET Form 4
Insider Selling Ares Private Markets Fund

Ares Private Markets Fund Insider Ares Capital Management II LLC Sells $20M of Stock

Ares Capital Management II LLC sold 484,652 shares of Ares Private Markets Fund at $41.27 a share, worth $20M in total on Oct 30, 2026. Shares held after the trade: 2,519,348 (-16.1%).

Value
$20M
Shares
484,652
Price
$41.27
Holding change
-16.1%
Trade date
Oct 30, 2026
8:35 PM ET Form 4
Insider Buying Stride, Inc. LRN

Stride Insider Dylan G. Haggart Buys $17.6M of Stock

Dylan G. Haggart bought 228,057 shares of Stride, Inc. at $74.07 to $78.51 a share (average $77.06) in 7 transactions, worth $17.6M in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 2,127,760 (+1.5%).

Value
$17.6M
Shares
228,057
Average price
$77.06
Holding change
+1.5%
Trade date
Oct 30, 2026 to Nov 3, 2026
8:23 PM ET Form 4
Insider Selling Rocket Lab Corp RKLB

Rocket Lab Insider Nina Armagno Sells $571K of Stock

Nina Armagno sold 10,826 shares of Rocket Lab Corp at $51.31 to $54.34 a share (average $52.76) in 4 transactions, worth $571K in total on Nov 2, 2026. Shares held after the trade: 100,596 (-2.2%).

Value
$571K
Shares
10,826
Average price
$52.76
Holding change
-2.2%
Trade date
Nov 2, 2026
8:22 PM ET Form 4
Insider Selling Rocket Lab Corp RKLB

Rocket Lab CFO Adam C. Spice Sells $7.4M of Stock

Adam C. Spice, CFO, sold 140,157 shares of Rocket Lab Corp at $51.28 to $54.78 a share (average $52.79) in 5 transactions, worth $7.4M in total on Nov 2, 2026. Shares held after the trade: 1,155,967 (-0.6%).

Value
$7.4M
Shares
140,157
Average price
$52.79
Role
CFO
Holding change
-0.6%
Trade date
Nov 2, 2026
7:55 PM ET Form 4
Insider Buying NPK International Inc. NPKI

NPK International Insider John C. Minge Buys $139K of Stock

John C. Minge bought 15,000 shares of NPK International Inc. at $9.24 a share, worth $139K in total on Nov 2, 2026. Shares held after the trade: 268,942 (+5.9%).

Value
$139K
Shares
15,000
Price
$9.24
Holding change
+5.9%
Trade date
Nov 2, 2026
7:52 PM ET Form 4
Insider Selling Adaptive Biotechnologies Corp ADPT

Adaptive Biotechnologies President and COO Julie Rubinstein Sells $929K of Stock

Julie Rubinstein, President and COO, sold 35,643 shares of Adaptive Biotechnologies Corp at $25.23 to $27.45 a share (average $26.06) in 5 transactions, worth $929K in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 377,802 (-3.0%).

Value
$929K
Shares
35,643
Average price
$26.06
Role
President and COO
Holding change
-3.0%
Trade date
Oct 30, 2026 to Nov 3, 2026
7:48 PM ET Form 4
Insider Selling Navan, Inc. NAVN

Navan Chairperson and CEO Ariel M. Cohen Sells $210K of Stock

Ariel M. Cohen, Chairperson and CEO, sold 8,033 shares of Navan, Inc. at $26.13 a share, worth $210K in total on Nov 2, 2026. Shares held after the trade: 1,027,562 (-0.8%).

Value
$210K
Shares
8,033
Price
$26.13
Role
Chairperson and CEO
Holding change
-0.8%
Trade date
Nov 2, 2026
7:39 PM ET Form 4
Insider Selling Ligand Pharmaceuticals Inc LGND

Ligand Pharmaceuticals Insider Jason Aryeh Sells $676K of Stock

Jason Aryeh sold 2,111 shares of Ligand Pharmaceuticals Inc at $317.74 to $320.49 a share (average $320.30) in 6 transactions, worth $676K in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 108,758 (-0.6%).

Value
$676K
Shares
2,111
Average price
$320.30
Holding change
-0.6%
Trade date
Oct 30, 2026 to Nov 2, 2026
7:37 PM ET Form 4
Insider Buying Boeing Co BA

Boeing Insider Mortimer J. Buckley Buys $998K of Stock

Mortimer J. Buckley bought 5,820 shares of Boeing Co at $171.55 a share, worth $998K in total on Oct 30, 2026. Shares held after the trade: 10,250 (+131.4%).

Value
$998K
Shares
5,820
Price
$171.55
Holding change
+131.4%
Trade date
Oct 30, 2026
7:37 PM ET Form 4
Insider Buying Boeing Co BA

Boeing Insider Steven M. Mollenkopf Buys $510K of Stock

Steven M. Mollenkopf bought 2,950 shares of Boeing Co at $173.03 a share, worth $510K in total on Oct 30, 2026. Shares held after the trade: 6,717 (+78.3%).

Value
$510K
Shares
2,950
Price
$173.03
Holding change
+78.3%
Trade date
Oct 30, 2026
7:30 PM ET Form 4
Insider Selling Kiniksa Pharmaceuticals International, plc KNSA

Kiniksa Pharmaceuticals International Chairman & CEO Sanj K. Patel Sells $37.4M of Stock

Sanj K. Patel, Chairman & CEO, sold 402,394 shares of Kiniksa Pharmaceuticals International, plc at $90.77 to $98.16 a share (average $92.92) in 14 transactions, worth $37.4M in total between Oct 30, 2026 and Nov 3, 2026. Shares held after the trade: 780,037 (-0.6%).

Value
$37.4M
Shares
402,394
Average price
$92.92
Role
Chairman & CEO
Holding change
-0.6%
Trade date
Oct 30, 2026 to Nov 3, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.